American Vein & Vascular Institute

What American Vein & Vascular Institute does

American Vein & Vascular Institute is a family-owned, physician-led outpatient medical practice specializing in the diagnosis and treatment of venous and vascular disease. Founded in 2009 in Pueblo, Colorado by Dr. Gordon Gibbs and Erin Reilly Gibbs, the company has expanded into the largest dedicated vein and vascular network in Colorado, operating nine clinics across the state plus a satellite location in Nebraska. The patient base is composed of individual adults referred by primary-care physicians or self-referred for conditions such as varicose veins, chronic venous insufficiency, and related circulatory disorders, with the 2024 addition of uterine fibroid embolization extending the addressable population into women's health.

The clinical model is built on a standardized, multi-site care delivery platform rather than on a single flagship location. Procedures offered include endovenous laser ablation, radiofrequency ablation, sclerotherapy, the VenaSeal closure system, and — most recently — uterine fibroid embolization. An in-house fellowship program trains the next cohort of vein specialists, serving both as a recruiting tool and as a mechanism for enforcing clinical protocol consistency across the network. The 2014 rebrand from the original Pueblo practice identity to "American Vein & Vascular Institute" formalized the shift from a single-clinic operation to a multi-state, multi-line brand, and a 2015 restructuring reorganized operations into four clinical service lines to support standardized protocols and cross-clinic staffing.

Revenue is generated on a fee-for-service basis, billed primarily through commercial insurance, Medicare, and Medicaid for covered vascular procedures. The company is privately held with no disclosed external funding rounds; growth has been financed internally from operating cash flow. Go-to-market combines a hub-and-spoke clinic footprint concentrated in Colorado with physician referral networks and direct-to-patient marketing. The 2013 ColoradoBiz Top 250 Private Companies ranking at #135 and a documented 1,200% growth rate between January 2010 and October 2013 indicate a company that scaled aggressively in its first half-decade, with continued clinic and service-line expansion supporting more recent growth.

Name

American Vein & Vascular Institute

Legal name

American Vein & Vascular Institute

Website

https://americanvein.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

101–250 employees

Short description

American Vein & Vascular Institute is a family-owned, physician-led outpatient practice operating nine Colorado clinics plus a Nebraska satellite, specializing in the diagnosis and treatment of venous and vascular disease for adult patients on a fee-for-service, insurance-billed basis.

Ownership category

akta.pro rank

Product category

Vein and Vascular Care

NAICS

Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Vascular Medicine (Peripheral Arterial/Venous Disease) (HLAKABAG)

Keywords

• Vein disease treatment
• Vascular diagnostics
• Minimally invasive phlebology
• Peripheral arterial disease care
• Compression therapy services

Headquarters

HQ city

Canon City

HQ country

United States

HQ region

North America

Offices11 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Insurance-reimbursed medical vein and vascular treatments: Core revenue from diagnostic and procedural vein care (radiofrequency ablation, endovenous laser ablation, sclerotherapy, phlebectomy, PAD interventions, UFE, VenaSeal). Most treatments for symptomatic vein disease are covered by Medicare, Medicaid, and major commercial insurance; the company handles pre-authorization in-house.
2. Self-pay cosmetic sclerotherapy services: Cosmetic spider vein and surface vein sclerotherapy priced as Initial Consult $125 and One Sclerotherapy Session $500. Most insurance carriers consider these treatments cosmetic and do not cover them.
3. Retail compression center sales: Retail sales of medical-grade compression stockings, socks, and sleeves with custom fittings at every Colorado clinic; no appointment needed.
4. Vascular diagnostic lab services (The Diagnostic Center): Revenue from accredited vascular diagnostic testing (venous insufficiency/DVT, PAD, extracranial cerebrovascular, visceral vascular) performed in-house and referred by external physicians.

Pricing tiers

Go-to-market motion3 records

Distribution channels1 record

Marketing channels8 records

Core offering

American Vein & Vascular Institute is a family-owned medical practice that diagnoses and treats venous disease, varicose veins, spider veins, chronic venous insufficiency, peripheral arterial disease, and related vascular conditions. The company operates the largest network of vein clinics in Colorado, providing minimally invasive procedures (endovenous ablation, sclerotherapy, VenaSeal, phlebectomy, UFE), IAC-accredited vascular diagnostic ultrasound, and retail compression therapy across multiple clinic locations.

Product overview

American Vein & Vascular Institute operates a multi-module, platform-style service portfolio rather than a single product. Its core is The Vein Center, which provides minimally invasive diagnosis and treatment of venous disease (varicose veins, spider veins, chronic venous insufficiency), supported by several integrated modules: the Diagnostic Center (IAC-accredited vascular lab with RVT/RPhS sonographers), the Cosmetic Center (cosmetic sclerotherapy), the Compression Center (medical-grade compression retail), and The Vascular Center (PAD program). Treatment modules within the Vein Center include Sclerotherapy (liquid and foam), Radiofrequency Ablation, Laser Ablation (EVLT), Phlebectomy, the Medtronic VenaSeal Closure System, and Uterine Fibroid Embolization (UFE). Digital touchpoints include a NextGen-powered Patient Portal and a referring physician portal with same-day reporting. Together, these products form a comprehensive vein-and-vascular care network across Colorado (and historically Texas) under a unified American Vein & Vascular Institute brand.

Differentiator

Problem solved

Functional benefit

Brands

• The Diagnostic Center: Fully accredited vascular diagnostic center offering comprehensive testing for venous, peripheral arterial, extra-cranial cerebrovascular, and visceral vascular disease; staffed by RVT and RPhS certified sonographers.
• The Compression Center
• The Cosmetic Center
• The Vein Center

Products and services

• Vein Center Core service line offering diagnosis and minimally invasive treatment of venous disease including varicose veins, spider veins, and chronic venous insufficiency. Provides vein disease treatments, vein screenings, and personalized treatment plans across all Colorado clinics. Targeted at adult patients with symptomatic venous disease.
• Cosmetic Center Cosmetic service line offering sclerotherapy treatments for varicose and spider veins, with transparent self-pay pricing (initial consult $125, per-session sclerotherapy $500). Designed for cosmetic (typically non-insurance-covered) vein care for patients seeking aesthetic improvement.
• Compression Center Retail service line providing medical-grade compression stockings, socks, and sleeves with custom fitting at all Colorado clinics. Serves as a conservative treatment option for varicose veins, spider veins, chronic venous insufficiency, and post-procedure recovery, as well as athletes, pregnant women, frequent flyers, and patients at DVT risk. Walk-in access with no appointment needed.
• Diagnostic Center Fully IAC-accredited vascular diagnostic lab at every clinic location, staffed by RVT and RPhS certified sonographers. Performs venous insufficiency/DVT testing, peripheral arterial disease (PAD) testing, extra-cranial cerebrovascular (carotid) ultrasound, and visceral vascular testing. Reports available same-day via online physician portal or within 24 hours.
• Vascular Center (Peripheral Arterial Disease Program) Service line for the diagnosis and treatment of peripheral artery disease (PAD), offering lifestyle counseling, angiogram with endovascular intervention (angioplasty, atherectomy, stent placement), and peripheral artery bypass. Targets patients 55+ and those with PAD risk factors.
• Uterine Fibroid Embolization (UFE) Minimally invasive, image-guided procedure that blocks the blood supply to uterine fibroids, performed by Dr. Paul J. Rochon. Marketed as a non-surgical, uterus-preserving, outpatient alternative to hysterectomy for women with symptomatic uterine fibroids.
• VenaSeal Closure System Treatment Non-thermal, non-tumescent treatment using a medical adhesive (by Medtronic) to seal diseased veins such as the great saphenous vein. FDA-approved in 2015, with ~94.6% five-year closure rate per the VeClose Extension Study. Featured as a key treatment option at American Vein & Vascular Institute.
• Patient Portal (NextGen-powered) Secure online portal (NextGen-hosted) giving patients access to health record updates after every appointment, appointment management, secure messaging with photos/attachments, access to ultrasound and procedure reports, and quick requests for billing, scheduling, and medical records.

Quantifiable outcome

• 1,200% growth rate between January 2010 and October 2013
• +4 more outcomes

Named customers3 records

Segments6 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature6 records

Partnerships

Twelve partnerships are on record, tiered minor and core.

• CyraCom, LLCminorImplementation/ SI/ Consulting PartnerRMVI partnered with CyraCom to provide Over-the-Phone interpretation, translation, video remote interpretation, on-site interpretation, and testing/training to support a company-wide multilingual/multicultural healthcare services initiative for Limited English Proficiency (LEP) patients. CyraCom has been in business since 1995 and serves more than 2,000 healthcare clients.
• Best Vein CarecoreOthersBest Vein Care designated Rocky Mountain Vein Institute as a "Premier Center of Excellence," an industry designation tied to quality of vein care delivery.
• MedtroniccoreTechnology or IntegrationMedtronic's VenaSeal closure system is a featured treatment at American Vein & Vascular Institute. Dr. Gordon Gibbs holds a "Faculty Instructor – Medtronic" role, indicating a clinical training and education relationship with the device manufacturer.
• Vascular InsightsminorStrategic or Co-development PartnerDr. Gordon Gibbs is a Principal Investigator with Vascular Insights, which designs, develops, manufactures, and markets medical devices for the minimally invasive treatment of peripheral vascular disease.
• St. Mary-Corwin Medical CentercoreStrategic or Co-development PartnerDr. Gordon Gibbs is Medical Director of Diagnostic and Interventional Radiology at St. Mary-Corwin Medical Center in Pueblo. CEO Erin Reilly Gibbs serves on the St. Mary-Corwin Foundation Board.
• CSU-Pueblo Foundation BoardminorOthersCEO Erin Reilly Gibbs sits on the CSU-Pueblo Foundation Board.
• Breast Center of Excellence (BCOE)minorGTM or Marketing PartnerErin Reilly Gibbs serves as campaign chairwoman for Breast Center of Excellence (BCOE), where she led the launch of a $1.5 million campaign.
• Vail Valley Medical Center and Starting HeartsminorGTM or Marketing PartnerRMVI provided free public ultrasound screenings of leg veins and carotid arteries at the first annual "All You Need is Heart" Heart Health Expo and Breakfast, hosted by Vail Valley Medical Center and Starting Hearts at The Sebastian in Vail on Feb. 14.
• NextGen Healthcare (Patient Portal)coreTechnology or IntegrationAmerican Vein & Vascular Institute runs its Patient Portal on NextGen (pxpportal.nextgen.com) to deliver health record updates, appointment management, secure messaging, report access, and "Ask a Question" requests.
• Parkview Medical CenterminorStrategic or Co-development PartnerDr. Timothy Cawlfield holds a hospital affiliation with Parkview Medical Center in Pueblo, Colorado, supporting continuity of care for AV&VI patients requiring hospital-based services.
• American Heart Association (AHA)minorGTM or Marketing PartnerDr. Terry Gordon, 2002 American Heart Association National Physician of the Year, served as keynote speaker at the Heart Health Expo co-sponsored by RMVI.
• Susana Clar (multicultural marketing consultant)minorGTM or Marketing PartnerRMVI hired Susana Clar to lead the Latino-market phase of its multilingual initiative, including translation of all internal documents and forms into Spanish.

Scale indicators9 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Center for Vein Restoration: Center for Vein Restoration is the largest physician-led vein clinic network in the United States with 100+ locations across more than 20 states. It offers the same core menu (RFA, EVLT, sclerotherapy, VenaSeal, phlebectomy, cosmetic vein care, vascular diagnostics) under an insurance-driven, multi-site clinic model, making it the closest comparable to American Vein & Vascular Institute.
• USA Vein Clinics: USA Vein Clinics operates a multi-state network of outpatient vein and vascular treatment centers offering endovenous laser ablation, radiofrequency ablation, sclerotherapy, and vascular diagnostics. Its multi-clinic, insurance-reimbursed model and focus on minimally invasive venous disease directly mirrors AV&VI's service portfolio and GTM motion.
• Metro Vein Centers: Metro Vein Centers is a multi-site vein clinic chain operating across New York, New Jersey, Texas, and Michigan, offering RFA, EVLT, sclerotherapy, VenaSeal, and cosmetic vein treatments under an insurance-based model. Comparable to AV&VI in service mix, payer reliance, and consumer-facing DTC marketing.
• Inovia Vein: Inovia Vein operates multiple vein specialty clinics in the Pacific Northwest (Oregon, Washington) and additional markets, offering minimally invasive venous treatments, ultrasound diagnostics, and cosmetic sclerotherapy. Closely comparable to AV&VI in clinic-format service mix and physician-led operations.
• Vein Clinics of America (now Inovia Vein Specialty Centers): Vein Clinics of America historically operated one of the largest U.S. networks of vein treatment centers across 15+ states; the brand/network has continued under new ownership. Closely comparable to AV&VI in its multi-state, minimally invasive vein-treatment clinic model.

Regional players

• Advanced Vein & Vascular Center: Advanced Vein & Vascular Center operates multi-clinic vein and vascular practices in Nevada/Utah with RFA, sclerotherapy, VenaSeal, and PAD services. Comparable to AV&VI in its physician-led, multi-clinic vein-and-vascular model, but serves a different regional footprint.
• Hamburg Vein Center / Vein Center of Cincinnati: Independent regional vein specialty practices offer the same minimally invasive venous procedures as AV&VI (RFA, EVLT, sclerotherapy, VenaSeal) under a single- or multi-clinic model. Comparable in clinical menu and patient mix but lacks AV&VI's statewide Colorado density and IAC-accredited diagnostic network.

Others

• Medtronic (Vascular / Venous portfolio): Medtronic manufactures the VenaSeal closure system that AV&VI prominently features, and Dr. Gibbs serves on its faculty. As the device manufacturer enabling a key differentiator in AV&VI's treatment menu, Medtronic is an enabling/partner rather than a competitor, but its product roadmap and pricing directly shape AV&VI's economics.

Broad incumbents

• Tenet Healthcare / United Surgical Partners International (USPI): Tenet/USPI operates a large network of ambulatory surgery centers and outpatient vascular services nationally. While not a vein-specialty competitor, its scale, payer contracts, and capital base allow it to expand outpatient vascular offerings that compete with AV&VI for the same patient pool in markets it enters.
• HCA Healthcare (Heart & Vascular service line): HCA Healthcare operates hospital-based and outpatient vascular programs across its 180+ hospitals. As a broad incumbent in vascular care, HCA represents the system-level competitive backdrop (in-network access, scale, and outpatient expansion) that AV&VI must compete against in its Colorado markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/rocky-mountain-vein-institute

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about American Vein & Vascular Institute